Insights

Strategic Growth Kolosis is expanding its orthobiologics portfolio with new launches such as APEXecm and Summit Matrix, signaling growing opportunities to cross-sell biologics products to spine, orthopedic, and cardiac surgery customers.

Key Hire Signals Recent leadership appointments including Area Vice Presidents and a Chief Financial Officer indicate organizational scaling and potential for expanded field sales, channel partnerships, and region-specific account growth.

Regional Focus Appointment of regional managers and AVP roles in multiple regions suggests targeting regional hospital systems and surgical centers with tailored geography-based outreach and channel strategies.

Financial Traction Reported revenue in the mid single-digit tens of millions implies a growing but still agile company, presenting opportunities to introduce additional biologics lines, higher-value implants, and bundled solutions to expand average deal size.

Strategic Partnerships Engagement with notable partners like MTF Biologics for orthopedic and spinal solutions points to collaborative selling opportunities and potential co-marketing, distribution expansion, and integrated product offerings.

Similar companies to Kolosis

Kolosis Tech Stack

Kolosis uses 8 technology products and services including WordPress, Salesforce, Dropbox, and more. Explore Kolosis's tech stack below.

Media & News

Kolosis's Email Address Formats

Kolosis uses at least 1 email format:
Kolosis Email FormatsExamplePercentage
FLast@kolosis.comJDoe@kolosis.com
100%

Frequently Asked Questions

What is Kolosis's official website and social media links?

Minus sign iconPlus sign icon
Kolosis's official website is kolosis.com and has social profiles on LinkedIn.

How much revenue does Kolosis generate?

Minus sign iconPlus sign icon
As of November 2026, Kolosis's annual revenue is estimated to be $10M - $25M.

What is Kolosis's SIC code and NAICS code?

Minus sign iconPlus sign icon
Kolosis's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kolosis have currently?

Minus sign iconPlus sign icon
As of November 2026, Kolosis has approximately 26 employees across 4 continents, including North America, Africa and Asia. Key team members include Area Vice President: C. C. and Robert C Md: R. K. Explore Kolosis's employee directory with LeadIQ.

What industry does Kolosis belong to?

Minus sign iconPlus sign icon
Kolosis operates in the Biotechnology Research industry.

What technology does Kolosis use?

Minus sign iconPlus sign icon
Kolosis's tech stack includes WordPress, Salesforce, Dropbox, Cloudflare DNS, Shopify, Microsoft 365, Google Tag Manager and Vimeo.

What is Kolosis's email format?

Minus sign iconPlus sign icon
Kolosis's email format typically follows the pattern of FLast@kolosis.com. Find more Kolosis email formats with LeadIQ.

When was Kolosis founded?

Minus sign iconPlus sign icon
Kolosis was founded in 2020.
Kolosis logo

Kolosis

Biotechnology ResearchUtah, United States11-50 Employees

Kolosis is a biotechnology company based in Salt Lake City, Utah, focused on developing and supplying biologics for spine, orthopedic, and cardiac surgery. As a pure-play biologics firm, it concentrates on technologies in the biologics space to support patient outcomes in these markets. The company emphasizes building high-performance sales channels across multiple medical disciplines, leveraging expertise in product marketing and brand development. Its commitment to scientific and clinical research underpins ongoing expansion of its product offerings to meet patient needs.

Based in Salt Lake City, Kolosis operates as a midsize biotechnology company focused on surgical biologics. In March 2026, the company launched APEXecm, expanding its portfolio of surgical biologics.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Kolosis's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.